Dupilumab Maintains Long-Term Disease Control in Adults With Moderate to Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial
Of, Adis Journals On Behalf ; Jashin J. Wu ; Spelman, Lynda ; Tan, Jerry L. ; Etoh, Takafumi ; Haixin Zhang ; Shumel, Brad ; Rossi, Ana B.